|
ASXL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.935700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.436800E-03 |
| Normal-vs-Stage2 |
5.624000E-01 |
| Normal-vs-Stage3 |
1.903210E-01 |
| Normal-vs-Stage4 |
1.673810E-01 |
| Stage1-vs-Stage2 |
4.029000E-01 |
| Stage1-vs-Stage3 |
6.571400E-01 |
| Stage1-vs-Stage4 |
7.249600E-01 |
| Stage2-vs-Stage3 |
6.828400E-01 |
| Stage2-vs-Stage4 |
3.965600E-01 |
| Stage3-vs-Stage4 |
5.298800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.319780E-02 |
| Normal-vs-AfricanAmerican |
1.291930E-02 |
| Normal-vs-Asian |
2.478800E-03 |
| Caucasian-vs-AfricanAmerican |
6.192400E-01 |
| Caucasian-vs-Asian |
3.618400E-01 |
| AfricanAmerican-vs-Asian |
3.803200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.648400E-04 |
| Normal-vs-Female |
5.496800E-01 |
| Male-vs-Female |
1.683160E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.880300E-02 |
| Normal-vs-Extreme_Weight |
3.60510000000369E-05 |
| Normal-vs-Obese |
4.107000E-01 |
| Normal-vs-Extreme_Obese |
1.266210E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.413400E-01 |
| Normal_Weight-vs-Obese |
1.979190E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.330000E-01 |
| Extreme_Weight-vs-Obese |
8.004300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.300600E-01 |
| Obese-vs-Extreme_Obese |
3.877800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.790800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.889580E-01 |
| Normal-vs-Age(61-80Yrs) |
1.476860E-03 |
| Normal-vs-Age(81-100Yrs) |
2.023100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.805000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.045400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.326610E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.485760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.290830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.227900E-04 |
| Normal-VS-Type2 PRCC |
8.812100E-02 |
| Normal-VS-KIRP CIMP |
5.823200E-01 |
| Normal-VS-Unclassified PRCC |
6.505400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.029600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.315700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.416100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.692970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.206360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.824000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.161100E-04 |
| Normal-vs-N1 |
9.676200E-01 |
| Normal-vs-N2 |
8.964200E-02 |
| N0-vs-N1 |
7.186100E-02 |
| N0-vs-N2 |
8.849200E-01 |
| N1-vs-N2 |
4.842200E-01 |
|
|
